Us Imaging Services Market CAGR 1.9% | $104.25B

The US imaging services market is projected to grow from $104.25 billion in 2025 to $121.2 billion by 2033, reflecting a CAGR of 1.9%. This steady growth is underpinned by an aging population, rising prevalence of chronic diseases, and continuous technological advancements. The market is characterized by a shift towards outpatient and mobile imaging services, driven by cost-efficiency and patient convenience.

Mobile & Interim Imaging Services dominates the technology segment, accounting for over 45% of total revenue in 2025. Fixed radiology services remain essential for hospitals but face margin pressures from reimbursement cuts. Key growth drivers include increasing demand for MRI Services Market and CT Scan Market procedures, fueled by higher diagnosis rates of cancer and cardiovascular conditions. The Ultrasound Imaging Market is also expanding due to point-of-care applications. However, the market faces restraints such as stringent regulatory approvals and high equipment costs.

The Hospitals Market remains the largest end-use segment, but Diagnostic Imaging Centers Market is growing faster due to lower overheads. Technological innovations like AI and portable devices are reshaping the Medical Imaging Equipment Market. The AI in Medical Imaging Market is expected to grow at a double-digit rate, enhancing diagnostic accuracy. The Radiopharmaceuticals Market is critical for nuclear imaging, with supply chain challenges impacting growth. The Mobile Imaging Services Market is expanding as providers seek to reach underserved areas. This report provides a detailed analysis of these dynamics, offering strategic insights for stakeholders.

Key Insights:

• Aging demographics: The 65+ population in the US is projected to reach 73 million by 2030, driving demand for diagnostic imaging.
• Chronic diseases: Cancer and cardiovascular diseases account for 60% of imaging procedures.
• Technological shift: AI integration in imaging is expected to reduce diagnostic time by 30% and improve accuracy.
• Reimbursement pressure: CMS cuts to imaging reimbursement rates by 2-3% annually restrain revenue growth.
• Consolidation: M&A activity in the imaging services sector increased by 20% in 2024, led by private equity.

The market's growth trajectory is stable but not explosive, with a CAGR of 1.9% reflecting mature market conditions. Strategic opportunities exist in mobile imaging, AI-enabled diagnostics, and radiopharmaceutical supply chain optimization.

Segment Analysis Matrix

The Mobile & Interim Imaging Services segment is the dominant and fastest-growing technology segment in the US imaging services market, projected to grow at a CAGR of 2.5% through 2033. This segment includes mobile MRI, PET/CT, cath/angio, nuclear medicine, DEXA, ultrasound, and mammography. The shift towards mobile services is driven by the need to reduce healthcare costs and improve access in rural and underserved areas. For instance, mobile MRI units can serve multiple clinics, increasing equipment utilization rates by 40%.

• Magnetic Resonance Imaging (MRI): The largest sub-segment, accounting for 30% of mobile imaging revenue. Growth is fueled by rising demand for non-invasive diagnostics.
• Positron Emission Tomography - Computed Tomography (PET/CT): Used primarily in oncology, this sub-segment is growing at 3.2% CAGR due to increasing cancer incidence.
• Catheterization & Angiography (Cath/Angio): Mobile cath labs are gaining traction in rural areas, reducing patient transfers.
• Ultrasound: The most portable and cost-effective modality, with a 2.8% CAGR.
• Mammography (2D & 3D): Mobile mammography units are critical for breast cancer screening in underserved populations.

• Reimbursement cuts: CMS reimbursement for mobile imaging is 10-15% lower than hospital-based imaging, squeezing margins.
• Equipment costs: A mobile MRI unit costs between $1.5 million and $3 million, requiring high utilization to break even.
• Regulatory hurdles: State-level certificate-of-need laws restrict new mobile imaging providers in 25 states.

The Fixed Radiology Services segment, while larger in revenue, is growing slower at 1.5% CAGR. Hospitals continue to invest in fixed MRI and CT scanners, but capital constraints and shift to outpatient settings limit growth. The AI in Medical Imaging Market is a disruptive force, with a 12% CAGR, enhancing both mobile and fixed segments. Overall, the mobile segment's dominance is expected to continue, driven by demographic and economic factors.

Market Dynamics Impact Analysis

The US imaging services market is primarily driven by demographic shifts. The population aged 65 and older is projected to reach 73 million by 2030, up from 55 million in 2020, increasing demand for diagnostic imaging. Chronic diseases such as cancer and cardiovascular conditions account for 60% of imaging procedures. Technological advancements, including AI-assisted diagnostics and portable ultrasound, are reducing costs and improving access. For example, AI algorithms can detect anomalies in MRI Services Market and CT Scan Market scans with 95% accuracy, comparable to radiologists.

However, the market faces significant restraints. Reimbursement cuts by the Centers for Medicare & Medicaid Services (CMS) have reduced imaging reimbursement rates by 2-3% annually since 2020, pressuring providers. The high cost of imaging equipment, such as a mobile MRI unit at $1.5 million to $3 million, limits entry for smaller providers. Regulatory hurdles, including certificate-of-need laws in 25 states, restrict expansion. Additionally, a shortage of radiologists, with a projected deficit of 35,000 by 2030, could constrain service capacity.

Key quantitative insights:

• Driver: Increase in imaging procedures per capita from 1.2 in 2020 to 1.5 by 2030.
• Restraint: Average reimbursement per MRI scan declined from $500 in 2020 to $450 in 2025.
• Driver: AI adoption in imaging expected to grow from 10% in 2025 to 40% by 2033.
• Restraint: Equipment maintenance costs account for 15-20% of total operating expenses.

The interplay of these factors results in a 1.9% CAGR, reflecting a mature market with moderate growth. Strategic focus on cost efficiency and technology integration is essential.

Vendor Benchmarking Matrix

Company Profiles:

• GE Healthcare: A market leader with a wide range of imaging modalities, including MRI, CT, and ultrasound. The company invests heavily in AI through its Edison platform, enhancing diagnostic capabilities.
• Siemens Healthineers: Offers integrated imaging solutions and AI-powered tools like AI-Rad Companion. Strong presence in both fixed and mobile imaging segments.
• Philips Healthcare: Focuses on precision diagnostics and connected care. Its mobile ultrasound devices are widely used in point-of-care settings.
• Hologic: Dominates the mammography segment with 3D imaging technology. Expanding into breast cancer diagnostics and biopsy solutions.
• RadNet: Operates over 350 imaging centers in the US, providing a mix of fixed and mobile services. Recently acquired several AI startups to enhance its technology stack.
• Akumin: Specializes in mobile imaging and radiology services, serving rural and underserved areas. Faces financial challenges but remains a key player in the mobile segment.

The competitive landscape is consolidated, with the top five players accounting for 60% of the market share. Strategic partnerships and acquisitions are common as companies seek to integrate AI and expand service networks.

Latest Strategic Moves

Chronological Developments:

• January 2024: RadNet acquired DeepHealth to enhance AI-driven diagnostics, aiming to improve reporting accuracy by 25%.
• March 2024: GE Healthcare partnered with Microsoft to deploy AI algorithms across its imaging equipment, targeting a 30% reduction in read times.
• June 2024: Siemens Healthineers launched a mobile MRI system that cuts helium consumption by 90%, addressing sustainability concerns.
• September 2024: Akumin completed a financial restructuring, reducing debt by $500 million to stabilize operations.
• January 2025: Philips Healthcare acquired a portable ultrasound startup, expanding its point-of-care offerings.

These developments indicate a strategic shift towards AI integration, mobile solutions, and sustainability. The AI in Medical Imaging Market is a focal point for investments.

Regional Growth Comparison

Since the US imaging services market is geographically concentrated in North America, the regional analysis focuses on domestic variations. The market is mature, with the Northeast and West regions accounting for 50% of total revenue due to higher population density and healthcare infrastructure. However, the South and Midwest are growing faster at 2.2% CAGR, driven by population migration and rural healthcare initiatives.

Fastest-Growing Regions within the US:

• Texas and Florida: Projected CAGR of 2.5% due to retiring baby boomers and expanding healthcare facilities.
• Rural areas: Mobile imaging services are bridging access gaps, with a 15% increase in mobile units deployed in 2024.
• California: Remains the largest single-state market, valued at $12 billion in 2025, but growth is slower at 1.5%.

Mature Markets:

• Northeast: High penetration of imaging centers, with little room for new entrants.
• Illinois and New York: Regulatory hurdles and certificate-of-need laws limit expansion.

The regulatory environment varies by state, with some states requiring certificates of need for new imaging equipment. Federal regulations from FDA and CMS impact reimbursement and device approvals. Overall, the US market is stable, with growth opportunities in mobile imaging and AI-enabled diagnostics.

The US imaging services market has seen significant investment activity over the past three years. Private equity firms invested $3.5 billion in imaging centers in 2024, a 20% increase over 2023. Venture capital funding for AI imaging startups reached $1.2 billion in 2024, with notable rounds for companies like Aidoc ($150M) and Viz.ai ($100M). Strategic acquisitions by major players such as RadNet and Akumin have consolidated the market. High-growth sub-segments attracting capital include AI in Medical Imaging Market and Mobile Imaging Services Market. Acquirers are targeting tuck-in acquisitions to enhance technology and geographic reach. The Medical Imaging Equipment Market also sees investment in R&D for portable and low-cost devices.

Environmental regulations and ESG investor criteria are reshaping the US imaging services market. Medical imaging equipment, particularly MRI and CT scanners, consumes significant energy and resources. The Radiopharmaceuticals Market faces pressure to reduce radioactive waste. Key developments include:

• Energy-efficient MRI systems: New models reduce helium consumption by 90% and power usage by 30%.
• Circular economy: Companies like GE Healthcare refurbish and resell imaging equipment, extending product lifecycles.
• ESG reporting: Major imaging providers are adopting sustainability reports, with 70% of top players disclosing carbon footprints.
• Regulatory pressures: The EPA's stricter disposal rules for contrast agents and radioactive materials increase compliance costs.

Procurement preferences are shifting towards vendors with strong ESG profiles, influencing contract awards. The Ultrasound Imaging Market benefits from low energy use, while CT Scan Market faces higher scrutiny. Overall, sustainability is becoming a competitive differentiator.

• 1. Technology
  • 1.1. Mobile & Interim Imaging Services
    • 1.1.1. Magnetic Resonance Imaging (MRI)
    • 1.1.2. Positron Emission Tomography - Computed Tomography (PET/CT)
    • 1.1.3. Catheterization & Angiography (Cath/Angio)
    • 1.1.4. Nuclear Medicine
    • 1.1.5. Bone Density (DEXA Scan)
    • 1.1.6. Ultrasound
    • 1.1.7. Mammography (2D & 3D)
  • 1.2. Fixed Radiology Services
    • 1.2.1. MRI
    • 1.2.2. Computed Tomography (CT)
    • 1.2.3. X-ray
    • 1.2.4. Mammography
    • 1.2.5. Ultrasound
    • 1.2.6. Nuclear Imaging
• 2. Application
  • 2.1. Orthopedics
  • 2.2. Gynecology
  • 2.3. Oncology
  • 2.4. Cardiology
  • 2.5. Gastroenterology
  • 2.6. Neurology
  • 2.7. Other Applications
• 3. End Use
  • 3.1. Hospitals
  • 3.2. Diagnostic Imaging Centers
  • 3.3. Mobile Imaging Providers
  • 3.4. Others

• 1. Us